FINANCIALS

KALV Kalvista Pharmaceuticals Inc 1348911

Income Statement
Revenue	kalv-20250131	50,000,000
Net Income	kalv-20250131	-42,268,000
Profit Margin		-84.54%

Balance Sheet
Current Assets	152,267,000
Assets	160,831,000
Current Liabilities	22,164,000
Liabilities	26,839,000
Equity	133,992,000
Shares Out	51,222,000

Cash Flow Statement
Operating Cash Flow	-79,862,000
Investing Cash Flow	85,835,000

Market Analysis
Market Cap	1,001,911,681
Price	19.56
BVPS	3.10
PB	3.91
PS	0.94
FCF	5,973,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view KALV documents filed with the SEC.

KALV Filings Clear

View A List of Tickers